REFERENCES
- Wong CF, Beshir S, Khalil A, Pai P, Ahmad R. Successful treatment of encapsulating peritoneal sclerosis with azathioprine and prednisolone. Perit Dial Int. 2005; 25: 285–294
- Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. Perit Dial Int. 2000; 20(Suppl. 4)S43–S55
- Eltoum MA, Wright S, Atchley J, Mason JC. Four consecutive cases of peritoneal dialysis-related encapsulating peritoneal sclerosis treated successfully with tamoxifen. Perit Dial Int. 2006; 26: 203–206
- Summers AM, Clancy MJ, Syed F, et al. Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int. 2005; 68: 2381–2388
- Wong CF. Clinical experience with Tamoxifen in encapsulating peritoneal sclerosis. Perit Dial Int. 2006; 26: 183–184
- Allaria PM, Giangrande A, Gandini E, Pisoni IB. Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent?. J Nephrol. 1999; 12: 395–397
- Turner MW, Holleman JH, Charlotte NC. Successful therapy of sclerosing peritonitis. Semin Dial. 1992; 5: 316
- Pollock CA. Bloody ascites in patient after transfer from peritoneal dialysis to hemodialysis. Semin Dial. 2003; 16: 406–410
- Evrenkaya TR, Atasoyu EM, Unver S, Basekim C, Baloglu H, Tulbek MY. Corticosteroid and tamoxifen therapy in sclerosing encapsulating peritonitis in a patient on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2004; 19: 2423–2424
- Moustafellos P, Hadjianastassiou V, Roy D, Velzeboer NE, Maniakyn N, Vaidya A, Friend PJ. Tamoxifen therapy in encapsulating sclerosing peritonitis in patients after kidney transplantation. Transplant Proc. Nov, 2006; 38(9)2913–2914